Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 68
Filter
1.
Neurogastroenterol Motil ; 29(11)2017 Nov.
Article in English | MEDLINE | ID: mdl-28560787

ABSTRACT

BACKGROUND: Changes to the structure and function of the innervation of the gut contribute to symptom generation in inflammatory bowel diseases (IBD). However, delineation of the mechanisms of these effects has proven difficult. Previous work on sympathetic neurons identified interleukin (IL)-17A as a novel neurotrophic cytokine. Since IL-17A is involved in IBD pathogenesis, we tested the hypothesis that IL-17A contributes to neuroanatomical remodeling during IBD. METHODS: Immunohistochemistry for tyrosine hydroxylase was used to identify sympathetic axons in mice with dextran sulphate sodium (DSS)-induced colitis and controls. Axon outgrowth from sympathetic neurons in response to incubation in cytokines or endoscopic patient biopsy supernatants was quantified. KEY RESULTS: DSS-induced colitis led to an increase in tyrosine hydroxylase immunoreactivity in the inflamed colon but not the spleen. Colonic supernatants from mice with colitis and biopsy supernatants from Crohn's disease patients increased axon outgrowth from mouse sympathetic neurons compared to supernatants from uninflamed controls. An antibody that neutralized IL-17A blocked the ability of DSS-induced colitis and Crohn's disease supernatants to induce axon extension. CONCLUSIONS AND INFERENCES: These findings identify IL-17A as a potential mediator of neuroanatomical remodeling of the gut innervation during IBD.


Subject(s)
Colitis/physiopathology , Crohn Disease/physiopathology , Inflammatory Bowel Diseases/physiopathology , Interleukin-17/physiology , Neuronal Plasticity , Sympathetic Nervous System/physiopathology , Adult , Aged , Axons/physiology , Colitis/chemically induced , Colitis/metabolism , Colon/innervation , Colon/physiopathology , Crohn Disease/metabolism , Dextran Sulfate/administration & dosage , Female , Humans , Inflammatory Bowel Diseases/metabolism , Interleukin-17/administration & dosage , Male , Middle Aged , Spleen/metabolism , Spleen/physiopathology , Sympathetic Fibers, Postganglionic/physiopathology , Tyrosine 3-Monooxygenase/metabolism , Young Adult
2.
Sex Transm Infect ; 93(1): 39-45, 2017 Feb.
Article in English | MEDLINE | ID: mdl-27382010

ABSTRACT

OBJECTIVES: Treatment of Neisseria gonorrhoeae is threatened by the emergence of antimicrobial resistance. We analysed data from the Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) in England and Wales to identify groups most at risk of reduced susceptibility to the currently recommended first-line therapy, ceftriaxone. METHODS: Data from GRASP between 2007 and 2013 on ceftriaxone susceptibility and strain types were analysed. Risk factors associated with isolates exhibiting a ceftriaxone minimum inhibitory concentration (MIC) of ≥0.015 mg/L (CTR ≥0.015 mg/L) were identified using logistic regression. RESULTS: One third of isolates from men who have sex with men (MSM) (1279/4203) and 9.9% from heterosexuals (458/4626) exhibited CTR ≥0.015 mg/L. Between 2007 and 2013, the modal MIC for isolates remained at 0.004 mg/L for MSM but increased from 0.002 to 0.004 mg/L for heterosexuals. Among MSM, CTR ≥0.015 mg/L was associated with Asian ethnicity (crude OR: 1.42; 95% CI 1.07 to 1.88) and previous gonorrhoea (1.34; 1.16 to 1.54). Among heterosexuals, CTR ≥0.015 mg/L was associated with older age (35+ years: 4.31; 3.34 to 5.55), ≥6 sexual partners (1.58; 1.01 to 2.44) and sex abroad (2.23; 1.71 to 2.91). CTR ≥0.015 mg/L was less likely in isolates from heterosexuals of black Caribbean or African ethnicity (0.29; 0.20 to 0.41, 0.66; 0.43 to 0.99), with a concurrent chlamydial infection (0.25; 0.19 to 0.34) or women (0.57; 0.46 to 0.71). Over 600 isolates (CTR ≥0.015 mg/L) were typed; the majority were in Genogroup 1407, containing sequence type 1407. CONCLUSIONS: The emergence and spread of gonorrhoea with reduced susceptibility to ceftriaxone seems a realistic prospect, most likely in those involved in 'rapid-transmission' or bridging sexual networks.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Ceftriaxone/therapeutic use , Drug Resistance, Multiple, Bacterial/drug effects , Gonorrhea/epidemiology , Neisseria gonorrhoeae/drug effects , Sexual Behavior/statistics & numerical data , Drug Resistance, Multiple, Bacterial/genetics , England/epidemiology , Factor Analysis, Statistical , Gonorrhea/drug therapy , Humans , Microbial Sensitivity Tests , Neisseria gonorrhoeae/isolation & purification , Prevalence , Risk Factors , Sentinel Surveillance , Sexual Partners , Treatment Failure , Wales/epidemiology
3.
Euro Surveill ; 19(45): 20955, 2014 Nov 13.
Article in English | MEDLINE | ID: mdl-25411689

ABSTRACT

Neisseria gonorrhoeae has consistently developed resistance to antimicrobials used therapeutically for gonorrhoea and few antimicrobials remain for effective empiric first-line therapy. Since 2009 the European gonococcal antimicrobial surveillance programme (Euro-GASP) has been running as a sentinel surveillance system across Member States of the European Union (EU) and European Economic Area (EEA) to monitor antimicrobial susceptibility in N. gonorrhoeae. During 2011, N. gonorrhoeae isolates were collected from 21 participating countries, and 7.6% and 0.5% of the examined gonococcal isolates had in vitro resistance to cefixime and ceftriaxone, respectively. The rate of ciprofloxacin and azithromycin resistance was 48.7% and 5.3%, respectively. Two (0.1%) isolates displayed high-level resistance to azithromycin, i.e. a minimum inhibitory concentration (MIC) ≥256 mg/L. The current report further highlights the public health need to implement the European response plan, including further strengthening of Euro-GASP, to control and manage the threat of multidrug resistant N. gonorrhoeae.


Subject(s)
Anti-Bacterial Agents/pharmacology , Cephalosporins/pharmacology , Gonorrhea/drug therapy , Microbial Sensitivity Tests/methods , Neisseria gonorrhoeae/drug effects , Anti-Bacterial Agents/therapeutic use , Azithromycin/pharmacology , Azithromycin/therapeutic use , Cefixime/pharmacology , Cefixime/therapeutic use , Ceftriaxone/pharmacology , Ceftriaxone/therapeutic use , Cephalosporins/therapeutic use , Ciprofloxacin/pharmacology , Ciprofloxacin/therapeutic use , Europe/epidemiology , European Union , Humans , Microbial Sensitivity Tests/statistics & numerical data , Neisseria gonorrhoeae/isolation & purification , Sentinel Surveillance
4.
Qual Prim Care ; 22(1): 43-51, 2014.
Article in English | MEDLINE | ID: mdl-24589150

ABSTRACT

BACKGROUND: The rising prevalence of obesity and diabetes in Kuwait represents a significant challenge for the country's healthcare system. Diabetes care in Scotland has improved by adopting a system of managed clinical networks supported by a national informatics platform. In 2010, a Kuwait-Dundee collaboration was established with a view to transforming diabetes care in Kuwait. This paper describes the significant progress that has been made to date. METHODS: The Kuwait-Scotland eHealth Innovation Network (KSeHIN) is a partnership among health, education, industry and government. KSeHIN aims to deliver a package of clinical service development, education (including a formal postgraduate programme and continuing professional development) and research underpinned by a comprehensive informatics system. RESULTS: The informatics system includes a disease registry for children and adults with diabetes. At the patient level, the system provides an overview of clinical and operational data. At the population level, users view key performance indicators based on national standards of diabetes care established by KSeHIN. The national childhood registry (CODeR) accumulates approximately 300 children a year. The adult registry (KHN), implemented in four primary healthcare centres in 2013, has approximately 4000 registered patients, most of whom are not yet meeting national clinical targets. A credit-bearing postgraduate educational programme provides module-based teaching and workplace-based projects. In addition, a new clinical skills centre provides simulator-based training. Over 150 masters students from throughout Kuwait are enrolled and over 400 work-based projects have been completed to date. CONCLUSION: KSeHIN represents a successful collaboration between multiple stakeholders working across traditional boundaries. It is targeting patient outcomes, system performance and professional development to provide a sustainable transformation in the quality of diabetes healthcare for the growing population of Kuwaitis with diabetes in Kuwait.


Subject(s)
Diabetes Mellitus/epidemiology , Health Personnel/education , Medical Informatics/organization & administration , Obesity/epidemiology , Patient Education as Topic/methods , Quality Assurance, Health Care/organization & administration , Adult , Child , Diabetes Mellitus/prevention & control , Diabetes Mellitus/therapy , Education, Graduate , Health Care Coalitions/organization & administration , Health Care Coalitions/standards , Humans , Interinstitutional Relations , International Cooperation , Kuwait/epidemiology , Medical Informatics/standards , Medical Informatics/trends , Obesity/complications , Obesity/therapy , Prevalence , Quality Assurance, Health Care/methods , Quality Assurance, Health Care/standards , Quality Improvement/organization & administration , Quality Improvement/standards , Registries , Scotland/epidemiology
5.
Int J Clin Pract ; 67(5): 462-8, 2013 May.
Article in English | MEDLINE | ID: mdl-23510057

ABSTRACT

AIMS: The Tayside insulin management (TIM) course is an intensive insulin management programme for adults with type 1 diabetes. The aim was to assess its effectiveness. METHODS: Haemoglobin A1c (HbA1c) and body mass index (BMI) from individuals with type 1 diabetes were collected 3 months before, and 6 and 24 months after the programme. The programme involved a full day of education per week for 4 weeks in a row. Quality of life was assessed using the standardised Audit of Diabetes-Dependent Quality of Life (ADDQoL) questionnaire completed both before and 3 months after the course. Subjects were also asked to complete a pre- and postcourse questionnaire gathering information about aspects of their diabetes management. In addition, individual satisfaction with course content and delivery was recorded. RESULTS: Participants had a median reduction in haemoglobin A1c (HbA1c) of 4 mmol/mol (0.4%) after 6 months and 5 mmol/mol (0.5%) 2 years after the course (p < 0.001). Mean daily dose of short-acting insulin decreased from 31.5 (1.9) units to 27.3 (1.9, p < 0.001). There was no significant change in BMI. There was an improvement in all 18 domains of the ADDQoL questionnaire. There was a decrease in hypoglycaemia unawareness from 34.3 ± 47.8% of patients to 8.6 ± 28% (p < 0.001), and a decrease in self-reported lipohypertrophy from 27.8% to 11.1% (p = 0.001). There was a significant reduction in the mean number of diabetic ketoacidosis and severe hypoglycaemic episodes. The number of blood glucose checks changed from 2.8 ± 2.1 to 3.2 ± 1.1 (p = 0.058) per day. Participant satisfaction with all aspects of course content and delivery was high. CONCLUSIONS: TIM is an effective intensive education programme for patients with type 1 diabetes.


Subject(s)
Diabetes Mellitus, Type 1/drug therapy , Hypoglycemic Agents/administration & dosage , Insulin, Short-Acting/administration & dosage , Patient Education as Topic/methods , Adult , Aged , Aged, 80 and over , Blood Glucose/metabolism , Diabetes Mellitus, Type 1/blood , Female , Glycated Hemoglobin/metabolism , Humans , Male , Medical Audit , Middle Aged , Program Evaluation , Quality of Life , Surveys and Questionnaires , Young Adult
6.
Environ Microbiol ; 15(5): 1356-76, 2013 May.
Article in English | MEDLINE | ID: mdl-23320838

ABSTRACT

The marine cyanobacteria Prochlorococcus and Synechococcus are highly abundant in the global oceans, as are the cyanophage with which they co-evolve. While genomic analyses have been relatively extensive for cyanomyoviruses, only three cyanopodoviruses isolated on marine cyanobacteria have been sequenced. Here we present nine new cyanopodovirus genomes, and analyse them in the context of the broader group. The genomes range from 42.2 to 47.7 kb, with G+C contents consistent with those of their hosts. They share 12 core genes, and the pan-genome is not close to being fully sampled. The genomes contain three variable island regions, with the most hypervariable genes concentrated at one end of the genome. Concatenated core-gene phylogeny clusters all but one of the phage into three distinct groups (MPP-A and two discrete clades within MPP-B). The outlier, P-RSP2, has the smallest genome and lacks RNA polymerase, a hallmark of the Autographivirinae subfamily. The phage in group MPP-B contain photosynthesis and carbon metabolism associated genes, while group MPP-A and the outlier P-RSP2 do not, suggesting different constraints on their lytic cycles. Four of the phage encode integrases and three have a host integration signature. Metagenomic analyses reveal that cyanopodoviruses may be more abundant in the oceans than previously thought.


Subject(s)
Cyanobacteria/virology , Genetic Variation , Genome, Viral/genetics , Phylogeny , Podoviridae/classification , Podoviridae/genetics , Seawater/microbiology , DNA-Directed DNA Polymerase/genetics , Genomic Islands/genetics , Metagenomics , Oceans and Seas , Prochlorococcus/virology , Sequence Alignment , Synechococcus/virology
7.
Euro Surveill ; 18(3)2013 Jan 17.
Article in English | MEDLINE | ID: mdl-23351652

ABSTRACT

Treatment of gonorrhoea is threatened by antimicrobial resistance, and decreased susceptibility and resistance to recommended therapies is emerging in Europe. Current associations between resistance and molecular type remain poorly understood. Gonococcal isolates (n=1,066) collected for the 2009 and 2010 European Gonococcal Antimicrobial Surveillance Programme were typed by Neisseria gonorrhoeae multi-antigen sequence typing (NG-MAST). A total of 406 sequence types (STs) were identified, 125 of which occurred in ≥two isolates. Seven major genogroups of closely related STs (varying by ≤1% at just one of the two target loci) were defined. Genogroup 1407 (G1407), observed in 20/21 countries and predominant in 13/21 countries, accounted for 23% of all isolates and was associated with decreased susceptibility to cefixime and resistance to ciprofloxacin and raised minimum inhibitory concentrations for ceftriaxone and azithromycin. Genogroup 225 (G225), associated with ciprofloxacin resistance, was observed in 10% of isolates from 19/21 countries. None of the other genogroups were associated with antimicrobial resistance. The predominance of a multidrug-resistant clone (G1407) in Europe is worrying given the recent reports of recommended third generation cephalosporins failing to treat infections with this clone. Identifying associations between ST and antimicrobial resistance aids the understanding of the dissemination of resistant clones within a population and could facilitate development of targeted intervention strategies.


Subject(s)
Anti-Bacterial Agents/pharmacology , Drug Resistance, Multiple, Bacterial/genetics , Gonorrhea/drug therapy , Multilocus Sequence Typing/methods , Neisseria gonorrhoeae/drug effects , Neisseria gonorrhoeae/genetics , Adolescent , Adult , Aged , Child , Child, Preschool , Europe/epidemiology , Gonorrhea/epidemiology , Gonorrhea/microbiology , Humans , Infant , Infant, Newborn , Microbial Sensitivity Tests , Middle Aged , Molecular Epidemiology , Neisseria gonorrhoeae/isolation & purification , Population Surveillance , Prevalence , Public Health , Treatment Outcome , Young Adult
8.
Int J Cardiol ; 163(3): 260-265, 2013 Mar 10.
Article in English | MEDLINE | ID: mdl-21703700

ABSTRACT

BACKGROUND: Surgical and other advances in the treatment and care of congenital heart disease have resulted in a significant increase in the number of adults with congenital heart disease (ACHD), many of whom have no regular cardiology follow-up. Optimised care for ACHD patients requires continuity of specialist and shared care and education of practitioners and patients. The challenges for managing ACHD were identified by a Health Needs Assessment in the North West and are addressed within the UK Department of Health's ACHD Commissioning Guide. MATERIALS AND METHODS: An ACHD model of care was recommended in the North West of England and developed by the three North West Cardiac & Stroke Networks. Within this, a Task Group focused on the role of primary care in the identification and continuing care of ACHD patients. A feasibility study demonstrated that existing diagnostic Read Codes can identify ACHD patients on general practice registers. An ACHD Toolkit was developed to provide algorithms to guide the appropriate management of ACHD patients through primary, secondary and/or specialist ACHD care and to improve education/knowledge amongst primary care staff about ACHD and its wider implications. RESULTS: Early findings during the development of this Toolkit illustrate a wide disparity of provision between current and optimal management strategies. Patients lost to follow-up have already been identified and their management modified. CONCLUSIONS: By focusing on identifying ACHD patients in primary care and organising/delivering ACHD services, the ACHD Toolkit could help to improve quality, timeliness of care, patient experience and wellbeing.


Subject(s)
Continuity of Patient Care/standards , Heart Defects, Congenital/therapy , Practice Guidelines as Topic/standards , Primary Health Care/standards , Adult , England/epidemiology , Feasibility Studies , Heart Defects, Congenital/diagnosis , Heart Defects, Congenital/epidemiology , Humans , Male , Middle Aged , Physicians, Primary Care/standards , Primary Health Care/methods
9.
Euro Surveill ; 16(42)2011 Oct 20.
Article in English | MEDLINE | ID: mdl-22027378

ABSTRACT

Neisseria gonorrhoeae antimicrobial susceptibility is monitored in the European Union (EU) and the European Economic Area (EEA) by the European gonococcal antimicrobial surveillance programme (Euro-GASP). Results from 17 EU/EEA Member States in 2009 showed that 5% of isolates had decreased susceptibility to cefixime, an upward trend in the minimum inhibitory concentrations of ceftriaxone and a high prevalence of resistance to ciprofloxacin (63%)and azithromycin (13%). These results are of public health value and highlight the need for healthcare professionals to be aware of possible cefixime treatment failures. Euro-GASP is being implemented in additional EU/EEA Member States to achieve greater representativeness. In addition, Euro-GASP aims to set up a system which will allow biannual reporting of antimicrobial resistance in the EU/EEA, with a transition from centralised towards decentralised testing,and will link epidemiological data to laboratory data to enhance surveillance. The benefits of this approach include more timely detection of emerging trends in gonococcal resistance across the EU/EEA and the provision of a robust evidence base for informing national and European guidelines for therapy.


Subject(s)
Anti-Bacterial Agents/pharmacology , Neisseria gonorrhoeae/drug effects , Drug Resistance, Bacterial , European Union , Humans , Microbial Sensitivity Tests , Population Surveillance
10.
Sex Transm Infect ; 85(6): 447-51, 2009 Oct.
Article in English | MEDLINE | ID: mdl-19497918

ABSTRACT

OBJECTIVE: To examine the molecular epidemiology of syphilis in Scotland. METHODS: Ulcer specimens were collected from 85 patients with infectious syphilis. Typing of Treponema pallidum was performed using a method that examines variation in two loci; the number of 60-basepair repeats within the arp gene and sequence variation in the tpr genes. RESULTS: Patients were predominately white men who have sex with men (MSM). Treponemal DNA was detected in 75 specimens and a total of six subtypes were identified from 58 typeable specimens (77%). The most common subtypes were 14d (44/58, 76%), followed by 14e (7/58, 12%), 14j (3/58, 5%), 14b (2/58, 3%), 14p and 14k (1/58, 2%). CONCLUSIONS: This study shows that subtype 14d is the predominant subtype circulating in Scotland and there is a surprising level of genetic diversity within the Scottish MSM community.


Subject(s)
Syphilis/epidemiology , Treponema pallidum/genetics , Adolescent , Adult , Aged , Ambulatory Care Facilities , Bacterial Typing Techniques/methods , DNA, Bacterial/genetics , Female , Fissure in Ano/microbiology , Genitalia/microbiology , Heterosexuality , Homosexuality, Male , Humans , Male , Middle Aged , Oral Ulcer/microbiology , Polymerase Chain Reaction/methods , Scotland/epidemiology , Syphilis/microbiology , Treponema pallidum/classification , Young Adult
11.
J Antimicrob Chemother ; 64(2): 353-8, 2009 Aug.
Article in English | MEDLINE | ID: mdl-19468025

ABSTRACT

OBJECTIVES: This study aimed to investigate the origin of high-level azithromycin resistance that emerged in isolates of Neisseria gonorrhoeae in England and Wales in 2007, and to establish methods for identifying high-level azithromycin resistance. METHODS: The Gonococcal Resistance to Antimicrobials Surveillance Programme (GRASP) data from 2001-07 were examined for emerging trends in azithromycin susceptibility. Further to the identification of six high-level azithromycin-resistant isolates in GRASP 2007, an additional 102 isolates were selected on the basis of azithromycin susceptibility and geographic origin from the GRASP 2006 and 2007 collections. Susceptibility testing by Etest and disc diffusion was performed on all 108 isolates and 75 of these were typed by N. gonorrhoeae multiantigen sequence typing. RESULTS: A slight drift towards higher MICs of azithromycin was observed in the gonococcal population since 2001. Of greater concern was the first example of a shift to high-level resistance observed in six isolates in 2007. All six isolates were sequence type 649, which was not observed in any of the lower-level azithromycin-resistant isolates from 2007 or in any isolates tested from the same geographical locations. Contact tracing data for one patient suggested a link with Scotland. Disc diffusion testing of all 108 isolates showed that azithromycin, but not erythromycin, discs can differentiate between low-level and high-level resistance. CONCLUSIONS: High-level azithromycin resistance has emerged in England and Wales. Contact tracing and typing data suggest this may have originated from Scotland. Surveillance of azithromycin resistance will be key in controlling its further dissemination.


Subject(s)
Anti-Bacterial Agents/pharmacology , Azithromycin/pharmacology , Drug Resistance, Bacterial , Gonorrhea/microbiology , Neisseria gonorrhoeae/drug effects , Adult , Bacterial Typing Techniques , Contact Tracing , England , Female , Genotype , Humans , Male , Microbial Sensitivity Tests , Neisseria gonorrhoeae/classification , Neisseria gonorrhoeae/genetics , Neisseria gonorrhoeae/isolation & purification , Sequence Analysis, DNA , Wales , Young Adult
12.
Am J Physiol Gastrointest Liver Physiol ; 296(2): G399-405, 2009 Feb.
Article in English | MEDLINE | ID: mdl-19074640

ABSTRACT

Evidence from patients with inflammatory bowel disease (IBD) and animal models suggests that inflammation alters blood flow to the mucosa, which precipitates mucosal barrier dysfunction. Impaired purinergic sympathetic regulation of submucosal arterioles, the resistance vessels of the splanchnic vasculature, is one of the defects identified during IBD and in mouse models of IBD. We hypothesized that this may be a consequence of upregulated catabolism of ATP during colitis. In vivo and in vitro video microscopy techniques were employed to measure the effects of purinergic agonists and inhibitors of CD39, an enzyme responsible for extracellular ATP catabolism, on the diameter of colonic submucosal arterioles from control mice and mice with dextran sodium sulfate [DSS, 5% (wt/vol)] colitis. Using a luciferase-based ATP assay, we examined the degradation of ATP and utilized real-time PCR, Western blotting, and immunohistochemistry to examine the expression and localization of CD39 during colitis. Arterioles from mice with DSS colitis did not constrict in response to ATP (10 microM) but did constrict in the presence of its nonhydrolyzable analog alpha,beta-methylene ATP (1 microM). alpha,beta-Methylene ADP (100 microM), an inhibitor of CD39, restored ATP-induced vasoconstriction in arterioles from mice with DSS-induced colitis. CD39 protein and mRNA expression was markedly increased during colitis. Immunohistochemical analysis demonstrated that, in addition to vascular CD39, F4/80-immunoreactive macrophages accounted for a large proportion of submucosal CD39 staining during colitis. These data implicate upregulation of CD39 in impaired sympathetic regulation of gastrointestinal blood flow during colitis.


Subject(s)
Adenosine Triphosphate/metabolism , Antigens, CD/metabolism , Apyrase/metabolism , Colitis/enzymology , Colon/blood supply , Splanchnic Circulation , Vasoconstriction , Adenosine Diphosphate/analogs & derivatives , Adenosine Diphosphate/pharmacology , Adenosine Triphosphate/analogs & derivatives , Adenosine Triphosphate/pharmacology , Animals , Antigens, CD/genetics , Antigens, Differentiation/metabolism , Apyrase/antagonists & inhibitors , Apyrase/genetics , Arterioles/immunology , Colitis/chemically induced , Colitis/physiopathology , Colon/drug effects , Colon/enzymology , Colon/innervation , Dextran Sulfate , Disease Models, Animal , Electric Stimulation , Enzyme Inhibitors/pharmacology , Macrophages/enzymology , Male , Mice , RNA, Messenger/metabolism , Splanchnic Circulation/drug effects , Submucous Plexus/enzymology , Sympathetic Nervous System/enzymology , Up-Regulation , Vasoconstriction/drug effects
14.
J Antimicrob Chemother ; 62(2): 303-15, 2008 Aug.
Article in English | MEDLINE | ID: mdl-18467308

ABSTRACT

OBJECTIVES: The aim of this study was to investigate the persistence of Campylobacter species, strain types, antibiotic resistance and mechanisms of tetracycline resistance in poultry flocks treated with chlortetracycline. METHODS: Three commercially reared broiler flocks, naturally colonized with Campylobacter, were treated with chlortetracycline under experimental conditions. The numbers of Campylobacter isolated, and the species, flaA short variable region allele, and antimicrobial resistance of isolates were determined. RESULTS: For two of three flocks, tetracycline-resistant strains predominated prior to chlortetracycline exposure. Presence of the antibiotic had no discernible effect on the numbers or types of Campylobacter and the tetracycline-resistant strains persisted in numbers similar to those observed before treatment. With all flocks, some faecal samples were obtained that contained no Campylobacter, irrespective of exposure to chlortetracycline; this was more common as the birds grew older. For the third flock, tetracycline-resistant Campylobacter were in the minority of samples before and during exposure to chlortetracycline, but at sampling times after this, no resistant strains were found in the treated (or untreated) birds, irrespective of exposure to the antibiotic. All tetracycline-resistant isolates (MICs 16 to >128 mg/L) contained tet(O) and, for some isolates, this was transferable to Campylobacter jejuni 81116. The efflux pump inhibitor PAbetaN reduced the MICs of tetracycline for these isolates by 4-fold, suggesting that an intact efflux pump, presumably CmeABC, is required for high-level tetracycline resistance. CONCLUSIONS: Our data indicate that chlortetracycline treatment does not eradicate tetracycline-resistant Campylobacter spp. from poultry. However, if a low number of resistant isolates are present, then the antibiotic pressure appears insufficient to select such strains as the dominant population.


Subject(s)
Anti-Bacterial Agents/pharmacology , Campylobacter/drug effects , Chlortetracycline/pharmacology , Poultry/microbiology , Tetracycline Resistance , Animals , Anti-Bacterial Agents/administration & dosage , Bacterial Proteins/genetics , Biological Transport, Active/drug effects , Campylobacter/classification , Campylobacter/isolation & purification , Carrier Proteins/genetics , Chlortetracycline/administration & dosage , Colony Count, Microbial , DNA, Bacterial/genetics , Dipeptides/pharmacology , Enzyme Inhibitors/pharmacology , Feces/microbiology , Flagellin/genetics , Gene Transfer, Horizontal , Microbial Sensitivity Tests
15.
Accid Anal Prev ; 40(2): 704-13, 2008 Mar.
Article in English | MEDLINE | ID: mdl-18329424

ABSTRACT

This study examined the effects of repeated iPod interactions on driver performance to determine if performance decrements decreased with practice. Nineteen younger drivers (mean age=19.4, range 18-22) participated in a seven session study in the University of Calgary Driving Simulator (UCDS). Drivers encountered a number of critical events on the roadways while interacting with an iPod including a pedestrian entering the roadway, a vehicle pullout, and a lead vehicle braking. Measures of hazard response, vehicle control, eye movements, and secondary task performance were analyzed. Increases in perception response time (PRT) and collisions were found while drivers were performing the difficult iPod tasks, which involved finding a specific song within the song titles menu. Over the course of the six experimental sessions, driving performance improved in all conditions. Difficult iPod interactions significantly increased the amount of visual attention directed into the vehicle above that of the baseline condition. With practice, slowed responses to driving hazards while interacting with the iPod declined somewhat, but a decrement still remained relative to the baseline condition. The multivariate results suggest that access to difficult iPod tasks while vehicles are in motion should be curtailed.


Subject(s)
Attention/physiology , Automobile Driving/psychology , Computer Simulation , Electronics , Eye Movements/physiology , Practice, Psychological , Adolescent , Adult , Auditory Perception/physiology , Automobile Driving/education , Female , Humans , Male , Pilot Projects , Reaction Time , Task Performance and Analysis , Vision Tests , Visual Perception/physiology
16.
Euro Surveill ; 12(7): E3-4, 2007 Jul 01.
Article in English | MEDLINE | ID: mdl-17991408

ABSTRACT

Antibiotic resistance is a key factor in the failure of Helicobacter pylori eradication therapy, yet few sentinel schemes exist to monitor trends in resistance at local, national or international levels. This study aimed, over a six-year period, to monitor resistance levels of H. pylori in England and Wales to the four antibiotics used in its treatment. A total of 1,310 isolates from Gwynedd in north Wales and from mid-Essex in south-east England were collected from 2000 to 2005 and tested for susceptibilities to metronidazole, clarithromycin, amoxicillin and tetracycline. Overall, metronidazole and clarithromycin resistance rates were 28.6% and 8.3% in Gwynedd and significantly higher (36.3%, p=0.0031, and 12.7%, p=0.0112) in mid-Essex. Rates of resistance to metronidazole and clarithromycin increased in both areas over this six-year period. Resistance rates were higher in female compared with male patients (38.1% vs 26.6% for metronidazole, p<0.0001, and 12.9% vs 7.5% for clarithromycin, p=0.0024), and were higher in patients <45 years compared with those ?45 years (44.0% vs 29.0% for metronidazole, p=0.0002, and 15.0% vs 9.4% for clarithromycin, p=0.0233). This study highlights the importance of antibiotic resistance surveillance in H. pylori for providing information on local resistance rates for test and treat strategies.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Drug Resistance, Bacterial , Helicobacter Infections/epidemiology , Helicobacter Infections/prevention & control , Helicobacter pylori/isolation & purification , Population Surveillance , Primary Prevention/statistics & numerical data , Adolescent , Adult , Aged , Child , Disease Outbreaks/statistics & numerical data , England/epidemiology , Female , Gastroenteritis/epidemiology , Gastroenteritis/prevention & control , Humans , Male , Middle Aged , Prevalence , Primary Prevention/methods , Wales/epidemiology
17.
Water Sci Technol ; 54(3): 147-52, 2006.
Article in English | MEDLINE | ID: mdl-17037146

ABSTRACT

Helicobacter pylori is an important global human pathogen and there is growing evidence from PCR assays that contaminated drinking water might be a possible source of infection in some circumstances. There are no validated protocols for direct isolation but various culture media have been developed for possible environmental sampling. Our aim here was to investigate how inter-strain variation might affect the interpretation of results with such media. Two laboratory adapted reference strains and four recent clinical isolates were tested on four solid media and in ten liquid media. Considerable variation was found between strains in their ability to recover on the different media after stress exposure (suspension in sterile tap water). Generally, clinical isolates were less robust than the laboratory-adapted strains and, overall, the former required longer recovery times. Our findings highlighted the importance of using a range of isolates for evaluations, as examination of laboratory-adapted strains alone did not provide an accurate representation of the utility of media that may be used to recover H. pylori from water.


Subject(s)
Helicobacter pylori/isolation & purification , Water Microbiology , Culture Media , Helicobacter pylori/growth & development , Species Specificity
18.
Aliment Pharmacol Ther ; 18(5): 481-6, 2003 Sep 01.
Article in English | MEDLINE | ID: mdl-12950420

ABSTRACT

BACKGROUND: Bacteria have been implicated in the pathogenesis of inflammatory bowel disease. Helicobacter species have been shown to cause colitis in animal models and have been identified in human diarrhoeal illness and Crohn's disease. AIM: To determine whether Helicobacter species are present in human inflammatory bowel disease tissue. METHODS: Thirty patients undergoing colonoscopy for clinical reasons were studied. Nine had Crohn's disease, 11 had ulcerative colitis and 10 had histologically normal colons. Tissue was snap-frozen at -70 degrees C. DNA was extracted and examined by five different polymerase chain reaction (PCR) assays that were either genus or species specific for Helicobacter. RESULTS: Analyses of colonic biopsies by two Helicobacter genus-specific PCR assays, two H. pylori-specific assays and a PCR assay designed to amplify fragments of 'H. heilmannii'-like organisms demonstrated that product was not generated by any test. Internal control PCR demonstrated that PCR results for the five assays were not negative due to the presence of residual substances inhibitory to PCR. CONCLUSIONS: Helicobacter species were not identified in this study, using multiple PCRs to eliminate the problems of non-specific cross-reaction. This suggests that Helicobacter species do not play a role in the pathogenesis of inflammatory bowel disease.


Subject(s)
DNA, Bacterial/genetics , Helicobacter Infections/genetics , Helicobacter/genetics , Inflammatory Bowel Diseases/microbiology , Adult , Aged , Female , Helicobacter pylori/genetics , Humans , Male , Middle Aged , Polymerase Chain Reaction/methods
19.
Vaccine ; 20(29-30): 3456-64, 2002 Oct 04.
Article in English | MEDLINE | ID: mdl-12297390

ABSTRACT

TA-CIN is a vaccine that comprises the human papillomavirus (HPV) type 16 L2, E6 and E7 as a single fusion protein. In a mouse model, TA-CIN effectively prevented outgrowth of HPV16-positive tumour cells. To assess the safety and immunogenicity of TA-CIN, a dose escalating (26, 128, 533 micro g), double blind and placebo-controlled phase I study was conducted in 40 healthy volunteers. TA-CIN was administered without adjuvant by intramuscular injection on weeks 0, 4 and 8. No serious adverse events of the vaccination were reported during the study. Both IgG antibodies and proliferative responses against TA-CIN were elicited at all three doses. More importantly, T-cell immunity against the HPV16 E6 and E7 oncoproteins was detected by IFN gamma ELISPOT in 8/11 evaluable subjects vaccinated with the 533 micro g dose.


Subject(s)
Capsid Proteins , Capsid/immunology , Oncogene Proteins, Viral/immunology , Papillomaviridae/immunology , Papillomavirus Vaccines , Repressor Proteins , T-Lymphocytes/immunology , Vaccines, Synthetic/immunology , Viral Vaccines/immunology , Adult , Antibodies, Viral/blood , Female , Humans , Immunization , Immunoglobulin G/blood , Male , Middle Aged , Papillomavirus E7 Proteins , Vaccination , Viral Vaccines/adverse effects
20.
Lett Appl Microbiol ; 35(1): 42-6, 2002.
Article in English | MEDLINE | ID: mdl-12081548

ABSTRACT

AIMS: To develop and evaluate a novel multiplex PCR assay that enables definition of Helicobacter pylori vacA allelic type in a single reaction. METHODS AND RESULTS: Application of the one-step system to DNA extracts from 22 cultures of known vacA genotype demonstrated that it was highly accurate. Analysis of 15 matched gastric biopsy/culture pairs generated exactly correlating genotype profiles. vacA genotypes were determined from an additional 62/70 gastric biopsies from dyspeptic patients of known H. pylori positive status by the one-step assay, compared with 63/70 by the original two-reaction test. Types s1/m1, s1/m2 and s2/m2 were identified in 51.9%, 31.2% and 16.9% of biopsies, respectively. CONCLUSIONS: The multiplex PCR system developed enables rapid one-step vacA genotyping that is accurate, easy to interpret and more economical than the alternative multiple-reaction tests. Application of this system to gastric biopsies from patients in South-east England demonstrated that s1/m1 was the most common genotype, while s1/m2 and s2/m2 were less prevalent. SIGNIFICANCE AND IMPACT OF THE STUDY: This simple one-step system can be applied direct to antral gastric biopsies without the need for culture, thereby facilitating rapid surveillance of vacA genotype in relation to geographical location and disease status.


Subject(s)
Bacterial Proteins/genetics , Helicobacter pylori/genetics , Polymerase Chain Reaction/methods , Alleles , Biopsy , DNA, Bacterial/analysis , Gastric Mucosa/microbiology , Genotype , Helicobacter Infections/microbiology , Helicobacter pylori/classification , Humans , Sensitivity and Specificity
SELECTION OF CITATIONS
SEARCH DETAIL
...